IMM 6.56% 28.5¢ immutep limited

IBBY, to be fair a biotech research company relies on successful...

  1. 17,805 Posts.
    lightbulb Created with Sketch. 235

    IBBY, to be fair a biotech research company relies on successful research which in turn

    relies on successful trial results.....These trials need to be funded somehow, couple of ways

    to do this, raise capital from investors or sell yourselves short....Management have alleviated

    costs to an extent through collaborative agreements...I don't know what else they can do....

    In saying that I do question the timing of this latest placement of which I will be questioning

    management this morning....When I get a reply I will pass it on....Have a great break my friend.

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
28.5¢
Change
-0.020(6.56%)
Mkt cap ! $486.6M
Open High Low Value Volume
30.5¢ 30.5¢ 28.5¢ $913.3K 3.099M

Buyers (Bids)

No. Vol. Price($)
6 124895 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 30287 2
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.